Neumora Therapeutics (NMRA) Property, Plant & Equipment (Net) (2022 - 2026)
Powered by 
Analysis
Neumora Therapeutics (NMRA) Property, Plant & Equipment (Net) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 2.06 Bn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 34.61 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 1.64 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 107.22 Mn |
| 10 | Neumora Therapeutics | 243.49 Mn | 243.49 Mn | - | 25,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25,000.00 |
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | 982,000.00 |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Dec 31, 2022 | 2.41 Mn |